NFE2L2 and acute kidney injury: In other studies, ATTM enabled nuclear factor erythroid 2-related factor 2 (NRF2) pathway activation, thereby protecting against arsenic-induced cardiovascular toxicity and cisplatin-induced acute kidney injury [170,171].